Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
A novel digital digit-symbol substitution test measures processing speed in adults at-risk for Alzheimer’s disease: A validation study
ABSTRACT
Background:
Assessing cognitive constructs affected by Alzheimer’s disease, such as processing speed (PS), is important to screen for potential disease and allow early detection. Digital PS assessments have been developed to provide widespread, efficient cognitive testing, but all have been validated only based on the correlation between test scores. Best statistical practices dictate that concurrent validity should be assessed for agreement or equivalence, rather than utilizing correlation alone.
Objective:
To assess the concurrent validity of a novel digital PS assessment against a gold-standard measure of PS.
Methods:
Adults aged 45-75 years (n = 191) participated in this study. Participants completed the novel digital digit symbol substitution test (DDSST) and the Repeatable Battery for the Assessment of Neuropsychological Status coding test (RBANS-C). The correlation between test scores was determined using a Pearson’s product moment correlation and a difference in mean test scores between tests was checked for using a dependent samples t-test. Data were analyzed for agreement between the two tests using Bland-Altman limits of agreement and equivalency using a two one-sided tests approach.
Results:
A significant moderate, positive correlation was found between DDSST and RBANS-C scores (r = .577, p < .001), and no difference in mean scores was detected between tests (p = 0.93). Scores between tests were found to display adequate agreement and equivalence (p = .049).
Conclusions:
Analyses indicate that the DDSST is a valid digital assessment of PS. The DDSST appears to be a suitable option for widespread, immediate, and efficient PS testing. Clinical Trial: ClinicalTrials.gov Identifier: NCT04559789 https://clinicaltrials.gov/ct2/show/NCT04559789
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.